|
ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC). |
|
|
Consulting or Advisory Role - Nektar; Novartis; Pfizer; Puma Biotechnology |
Research Funding - Genentech/Roche (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - Novartis |
|
|
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst) |
|
|
Honoraria - Eisai; Genentech; Genomic Health; Novartis |
Consulting or Advisory Role - Eisai; Nektar |
Speakers' Bureau - Eisai; Genentech; Genomic Health; Novartis |
Research Funding - Bayer; Novartis |
|
|
Consulting or Advisory Role - Angiochem; Genentech/Roche; GERON; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV |
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Geron (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Oncothyreon (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst) |
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com |
|
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Genomic Health |
Speakers' Bureau - Genomic Health |
Research Funding - Celsion (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst) |
Travel, Accommodations, Expenses - Bayer; Novartis; OBI Pharma; Pfizer; Roche/Genentech |
|
|
Honoraria - Daiichi Sankyo; Eisai; Nektar |
|
|
Consulting or Advisory Role - Abbvie; Lilly; Novartis; Pfizer; Roche/Genentech |
Speakers' Bureau - Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Leadership - NeoGenomics Laboratories |
Stock and Other Ownership Interests - NeoGenomics Laboratories |
Consulting or Advisory Role - Medivation; Nektar |
Travel, Accommodations, Expenses - Medivation; Nektar |
|
|
|
|
|
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Roche |